Fresenius Medical Care (ETR:FME) Shares Pass Above 200 Day Moving Average – Should You Sell?

Fresenius Medical Care AG (ETR:FME) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of €39.22 and traded as high as €42.54. Fresenius Medical Care shares last traded at €42.27, with a volume of 675,524 shares traded.

Fresenius Medical Care Stock Up 2.4%

The company has a debt-to-equity ratio of 83.29, a quick ratio of 0.80 and a current ratio of 1.20. The stock has a market cap of $12.80 billion, a price-to-earnings ratio of 19.42, a PEG ratio of 0.42 and a beta of 0.82. The firm’s 50-day simple moving average is €39.60 and its two-hundred day simple moving average is €39.22.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.